v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
CURRENT ASSETS:    
Cash and cash equivalents $ 40,778 $ 35,085
Restricted cash 500 957
Accounts receivable, less allowance of $534 and $1,372 as of March 31, 2026 and December 31, 2025, respectively 3,791 5,254
Unbilled receivables 2,006 1,268
Inventories 6,327 7,090
Prepaid expenses and other current assets 2,631 1,255
Total current assets 56,033 50,909
Property and equipment, net 2,503 2,549
Other long term assets 1,803 1,804
Total assets 60,339 55,262
CURRENT LIABILITIES:    
Accounts payable 4,552 4,051
Deferred grant funding 500 957
Deferred revenue 1,578 1,544
Accrued expenses and other current liabilities 3,468 5,130
Total current liabilities 10,154 11,732
Long-term debt, net 13,123 0
Warrant liabilities 1,971 1,730
Long term deferred revenue 713 729
Other noncurrent liabilities 17 66
Total liabilities 25,978 14,257
COMMITMENTS AND CONTINGENCIES (NOTE 14)
STOCKHOLDERS' EQUITY:    
Additional paid-in capital 372,990 371,011
Accumulated deficit (338,639) (330,016)
Total stockholders' equity 34,361 41,005
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 60,339 55,262
Related Party    
CURRENT LIABILITIES:    
Due to related parties 56 50
Class A Common Stock    
STOCKHOLDERS' EQUITY:    
Common stock 8 8
Class B Common Stock    
STOCKHOLDERS' EQUITY:    
Common stock $ 2 $ 2